Quantum Biopharma (QNTM) Minority Interest (2023 - 2026)
Quantum Biopharma recorded quarterly Minority Interest of -$193265.0 in Q1 2026, up 89.39% quarter-over-quarter from -$1.8 million in Q4 2025, and up 83.94% year-over-year from -$105069.1 in Q1 2025.
Quantum Biopharma's Minority Interest history runs 4 years deep, the most recent figure standing at -$193265.0 for Q1 2026.
- In Q1 2026, Minority Interest rose 83.94% year-over-year to -$193265.0; the TTM figure through Mar 2026 stood at -$193265.0 (up 83.94% YoY), while the FY2025 annual figure was -$1.8 million, down 75.13% from the prior year.
- Minority Interest came in at -$193265.0 for Q1 2026 at Quantum Biopharma, up from -$1.8 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $571429.0 in Q3 2025 to a low of -$1.8 million in Q4 2025.
- A 4-year average of -$705469.0 and a median of -$686462.0 in 2024 frame the typical range for Minority Interest.
- Across the five-year window, Minority Interest slumped 588.95% in 2024 and soared 192.65% in 2025, its largest moves.
- Quantum Biopharma's Minority Interest stood at -$89526.0 in 2023, then slumped by 1062.02% to -$1.0 million in 2024, then slumped by 75.13% to -$1.8 million in 2025, then soared by 89.39% to -$193265.0 in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered -$193265.0, -$1.8 million, and $571429.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193,265.00 |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | 571,429.00 |
| Jun 30, 2025 | -676,418.00 |
| Mar 31, 2025 | -1.20 Mn |
| Dec 31, 2024 | -1.04 Mn |
| Sep 30, 2024 | -616,790.00 |
| Jun 30, 2024 | -428,633.00 |
| Mar 31, 2024 | -188,050.00 |
| Sep 30, 2023 | -89,526.00 |